Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP428651.RALZ46cv-NsWKyweEhJT6v72K01qcT9jICfSnQgAYdZI4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP428651.RALZ46cv-NsWKyweEhJT6v72K01qcT9jICfSnQgAYdZI4130_assertion type Assertion NP428651.RALZ46cv-NsWKyweEhJT6v72K01qcT9jICfSnQgAYdZI4130_head.
- NP428651.RALZ46cv-NsWKyweEhJT6v72K01qcT9jICfSnQgAYdZI4130_assertion description "[Ecallantide is a potent and specific plasma kallikrein inhibitor approved for the treatment of acute attacks of HAE affecting any anatomic site.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP428651.RALZ46cv-NsWKyweEhJT6v72K01qcT9jICfSnQgAYdZI4130_provenance.
- NP428651.RALZ46cv-NsWKyweEhJT6v72K01qcT9jICfSnQgAYdZI4130_assertion evidence source_evidence_literature NP428651.RALZ46cv-NsWKyweEhJT6v72K01qcT9jICfSnQgAYdZI4130_provenance.
- NP428651.RALZ46cv-NsWKyweEhJT6v72K01qcT9jICfSnQgAYdZI4130_assertion SIO_000772 22149337 NP428651.RALZ46cv-NsWKyweEhJT6v72K01qcT9jICfSnQgAYdZI4130_provenance.
- NP428651.RALZ46cv-NsWKyweEhJT6v72K01qcT9jICfSnQgAYdZI4130_assertion wasDerivedFrom befree-20140225 NP428651.RALZ46cv-NsWKyweEhJT6v72K01qcT9jICfSnQgAYdZI4130_provenance.
- NP428651.RALZ46cv-NsWKyweEhJT6v72K01qcT9jICfSnQgAYdZI4130_assertion wasGeneratedBy ECO_0000203 NP428651.RALZ46cv-NsWKyweEhJT6v72K01qcT9jICfSnQgAYdZI4130_provenance.